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Objective: The notion that cooling vesicant-exposed tissue may ameliorate or prevent
resultant injury is not a novel concept. During both World Wars, studies were conducted
that investigated this potential mode of therapy with sulfur mustard and seemed to
conclude that there might be merit in pursuing this research direction. However, it does
notappearthatthesestudieswerefollowedupvigorously,andtheliteraturethatdescribes
thisworkisnotreadilyaccessible.Inthisreport,wecomparethetoxicitiesoflewisiteand
sulfur mustard in vitro and in vivo and also provide an overview of historical and recent
work on the effect of temperature on the toxicity of these vesicating chemical warfare
agents.Methods:Tissuecultureandanimalstudieswereutilizedtoexaminetheeffectsof
hypothermiaonvesicant-inducedtoxicity.Results:Cytotoxicitywaseithersignificantly
delayed (lewisite) or prevented (sulfur mustard) when cultures were maintained at 25◦C.
However,theeffectsofhypothermiaonsulfurmustard–inducedcelldeathwerereversible
when the cells were returned to 37◦C. Despite these in vitro results, animal studies
demonstrated that the therapeutic cooling of both mustard sulfur–exposed and lewisite-
exposed skin resulted in dramatic and permanent protection against injury. Cooling
also increased the therapeutic window in which drugs were effective against vesicant
agents in tissue culture and lewisite-induced skin injury. Conclusions: The simple and
noninvasiveapplicationofcoolingmeasuresmaynotonlyprovidesignificanttherapeutic
relieftovesicant-exposedskinbutalsoincreasethetherapeuticwindowinwhichmedical
countermeasures against vesicant agents are useful.
Thechemicalwarfare(CW)agentslewisite(dichloro[2-chlorovinyl]arsine)andsulfur
mustard (bis[(2-chloroethyl]sulfide) have been weaponized and stockpiled in a number of
countries around the world.1 Although the military use of both compounds is primarily as
incapacitants because of their potent vesicant activities, they can also induce a range of
toxic pathologies that result in death if exposure is high enough. In historical reports that
recount experimental work with these CW agents, it is unusual for the synthetic process by
which the munitions-grade products were produced (resulting in varying compositions of
the test agents) to be identified. In addition, these records seldom state whether the material
The authors dedicate this article to the memory of Dr Brennie Hackley, a valued friend and colleague to many
of us in the field of chemical biodefence.
232SAWYERA N DNELSON
used was distilled to produce a higher-purity test article. Therefore, for the purposes of this
overview, when it is not possible to identify what the makeup of the actual test agents is, we
will refer to them as either sulfur mustard or lewisite, and the distilled products as “HD”
and “L,” respectively.
Since its first use in 1917 by the Germans at Ypres, Belgium, sulfur mustard has been
utilized in a number of military conflicts. It has well-documented cytotoxic,2 mutagenic,3,4
and vesicant properties.5,6 At very high exposures, sulfur mustard also induces profound
systemiceffects,7–9 whichincludetheclassicsignsofastrongalkylatingpoisonaswellasa
shock-like syndrome that does not respond to treatment.10,11 Other than its well-understood
antimitoticeffects,themechanismoftoxicactionofthisCWagentisunknown,andantidotes
do not exist against its action.1,2,12,13
Lewisite was the result of American efforts to develop an arsenical vesicant to counter
German gas use during World War I. After an extensive research program, it was identified
as the lead candidate and weaponized in 1918.14 The toxicity and vesicant activity of this
compound in comparison with that of HD is unclear from the historical literature, with a
variety of reports describing it as having less-to-more vesicant activity.14 What is clear,
however, is that lewisite is a rapid acting and powerful vesicant and its arsenical makeup
renders it a potent cytotoxin and blood poison.15 In contrast to sulfur mustard, antidotes
against this potent vesicant have been developed. British anti-lewisite16 as well as other
less toxic, more water-soluble chelators17–21 have been shown to be effective in preventing
lewisite toxicity. Lewisite has not been convincingly documented as being used in the
battlefield1 and its utility as a CW agent has been debated.14 Nevertheless, it has been
extensively weaponized as a mixture with sulfur mustard, ostensibly to lower the freezing
temperature of the latter compound. Undoubtedly, use of this CW mixture would result in
painful and difficult-to-treat tissue injury, which heals slowly.
The modulatory effects of temperature on the toxicity of xenobiotics have long
been a topic of investigation. During the early part of the last century, the toxicity of
colchicine was shown to be dramatically temperature dependent, with its lethality in frogs
increasing several hundred folds with only a 12◦C increase in temperature.22 Subsequent
work showed that a large variety of drug actions were temperature dependent and by
1961, a review article identified more than 300 citations in this area.23 Indeed, there is
aw ealth of information available on how temperature modulates the metabolism, dis-
tribution, and excretion of a wide range of currently used pharmaceuticals as well as
the toxicity of selected xenobiotics.23–25 Although this research area does not seem to
have been as broadly active in recent years, the effects of both hypothermia and hyper-
thermia have been the topics of interest with respect to improving the efficacy of some
cancer chemotherapies.26–28 Tissue culture studies have shown the increased toxicity of
a number of compounds (notably alkylating agents such as Melphalan) with increased
temperature. These studies have led to successful clinical trials, using chemotherapy and
hyperthermia. Although the success of some of these trials has shown the utility of this
approach, the mechanism(s) by which hyperthermia enhances the toxicity of these drugs is
unclear, although a number of hypotheses have been advanced, including enhanced mem-
brane permeability, increased metabolic activation to toxic species, increased rate of hy-
drolysis, increased blood flow, and increased rate of reaction of the drug with critical
macromolecules.29–31
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In this report, we briefly compare the toxicities of lewisite and sulfur mustard both in
vitro and in vivo and also provide an overview of historical and recent work on the effect
of temperature on the toxicity of these vesicating CW agents.
METHODS
Cell culture
Seed cultures of J-774, CHO-K1, and HeLa cell lines were obtained from the American
Type Culture Collection (Manassas, Va). J-774 cells are a mouse macrophage–derived cell
line,CHO-K1cellsareastrainoftheepithelialcelllinederivedfromChinesehamsterovary
cells,andHeLacellswereoriginallyculturedfromahumancervicalcarcinoma.Thecultures
were grown in 10% foetal calf serum in Dulbecco’s Modified Eagle Medium supplemented
with streptomycin (100 µg/mL) and penicillin (100 IU/mL), and the medium was changed
as required. Stock cultures were closely monitored and not allowed to grow to confluency
beforebeingsubcultured.Testcultureswereusedjustbefore,orat,confluency.Themethods
for culturing human skin keratinocytes and chick embryo neurons have previously been
described.32–35
Chemical treatment
On the day of chemical treatment, the cultures were treated with the CW agent dissolved in
ethanolsothatthedesiredfinalagentconcentrationwasreachedat0.25%ethanol(vol/vol).
To assess cytotoxicity, alamarBlue was added (10%, vol/vol) to the cultures and allowed
to incubate for the last 3 to 5 hours of the routine 24 hour (cell lines, neurons) or 48-hour
(keratinocytes) treatment. The absorbances (570–600 nm) were then read on a Thermomax
titerplatereader(MolecularDevices,Sunnyvale,Calif).Thisassaymeasuresmetabolicvia-
bilityandwehavefoundittobeareliableindicatorofcytotoxicity,yieldingresultssimilarto
that obtained by more commonly used methods such as the neutral red and MTT assays.34
Median lethal concentration values were determined graphically from experiments, uti-
lizing 6 wells per data point. In all cases, values represent data from at least 3 separate
experiments. Studies investigating the effects of temperature on HD or L toxicity in neu-
rons and keratinocytes were carried out in humidified CO2 incubators set at 25◦C, 31◦C, or
37◦C. Munitions-grade sulfur mustard was distilled at Defence Research and Development
Canada–Suffield to greater than 98% purity. Munitions-grade lewisite was distilled and the
resultant product consisted of 79.9% dichloro (2-chlorovinyl) arsine (the desired lewisite
product), 0.9% bis(2-chlorovinyl) chloroarsine, and 17.9% unknown.33
Animal studies
Male hairless guinea pigs (strain Crl: IAF(HA)-hrBR) were acquired from Charles River
Laboratories (St Constant, Quebec, Canada). The animals were acclimated for at least 1
weekbeforeexperimentaluse.Inconductingthisresearch,theauthorsadheredtotheGuide
to the Care and Use of Experimental Animals and The Ethics of Animal Experimentation
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published by the Canadian Council on Animal Care. The methodology for HD and L skin
exposure, as well as cooling agent-exposed sites, has previously been described.32–35
RESULTS AND DISCUSSION
Historical vesicant hypothermia research
Some of the first work to investigate the effect of lowered temperature on sulfur mustard
toxicity appears to have been motivated by a then-popular theory of mustard toxicity. The
“hydrochloric acid theory of mustard vesication” (reviewed in Papirmeister et al2)h ypoth-
esized that the chemical hydrolysis of sulfur mustard within the cell resulted in sufficient
liberation of hydrochloric acid so as to cause cytotoxicity. In a review article by Lynch et
al,8 the authors reasoned that since the rate of sulfur mustard hydrolysis would be much
decreased by reducing the temperature, this should provide relief from its toxicity. In these
studies,catfishwereexposedtoa“quarter-saturated”solutionofsulfurmustardintapwater
for 5 minutes, or goldfish to a “half-saturated” solution of sulfur mustard in tap water for
10minutes,andthentransferredtoeitherroomtemperaturewater(24◦C–26◦C)orcoldwa-
ter(8◦C–10◦C).Ofthe10catfishthatwereplacedinroomtemperaturewater,alldiedwithin
28hours,exhibitinghemorrhagesonthefins,tails,andventralsurfaceswithin20hours.Five
of 7 catfish placed back into the cold water survived for the 5-day experimental treatment
with no signs of skin injury being observed. In the goldfish experiments, all 8 fish returned
to room temperature water died within 6 days, while all 7 fish returned to the cooler water
survived the 17-day test period. No skin injury was observed in the goldfish experiments.
The authors concluded, after conducting further studies demonstrating that the toxicity of
hydrochloricacidwasnottemperaturedependentinthese2species,that“theseexperiments
onfishtendtosubstantiatethetheoryofintracellularliberationofacid.”8 Althoughthepro-
tective effects of hypothermia against sulfur mustard were demonstrated in these studies, it
appears that these experiments largely summarized the work carried out with hypothermia
and mustard sulfur to this point in time, since this report was reproduced in its entirety in
a history of American medical countermeasures research against gas warfare published in
1926,36 with no mention of any additional related work.
Between the World Wars, a great deal of CW research was carried out by a number of
countries, since it was anticipated that the next major war would rely heavily on chemical
weaponry. However, to our knowledge, there is no record of work carried out on the effect
of lowered temperature on sulfur mustard injury. During World War II, while there was
aw ealth of research that supported the assertion that sulfur mustard–induced skin injury
was definitively more severe in hot and humid conditions (either occluded by clothes or in
tropical climates),2,37 relatively little work appears to have been carried out on the effects
of hypothermia. The focus of much of the work that did occur, appeared to use lowered
temperaturetodecreasetheamountof“fixed”(ornonextractable)sulfurmustardintheskin,
anendpointthatwasbelievedtobecorrelatedwiththeseverityofskininjury.37 Theoriginal
reporting of this work has not been possible for the authors to obtain. However, intriguing
hints exist that point to the efficacy (or lack thereof) of cooling sulfur mustard–exposed
tissue. Sir Frederick Banting, codiscoverer of insulin and a major supporter of Canada’s
chemical biological effort during the World War II, was said to have tested the effects of
ice-packtreatmentonhimselfin1940.Hewasdescribedasundergoinga5-minuteexposure
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of 100 mg of sulfur mustard spread over a 6.5 × 1.5-in area on his lower right leg, before
blotting the residual liquid off and applying ice. No toxicity was apparent until he had to
fight a grass fire the next afternoon and the ice melted, resulting in extremely serious and
painful injury. Despite this, the Canadian Medical Research Council apparently considered
the ice treatment to be a success.38
Figure 1. Reproduction of a page from a 1943 Chemical Warfare Laboratories (Ottawa,
Ontario, Canada) physiological note referring to successful therapeutic ice-pack treatments
to sulfur mustard–skin injury. Sulfur mustard is referred to as “H” while “S” refers to
nitrogen mustard-2.
Additionalintriguingevidencethatice-packtreatmentofsulfurmustard–exposedskin
mightbeofutilityisarecordofameetingheldbythePhysiologicalMechanismsCommittee
in New York City.39 On the last page of this document (Fig 1), there is a short discussion on
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the efficacy of ice-pack treatment on sulfur mustard–exposed skin with respect to lowering
theamountofnonextractablesulfurmustard,andpreventingskininjury.Threeyearslater,a
review of what appears to be related work is included in a treatise published, describing the
AlliedCWagentresearcheffort.40 Thechapteronmechanismsofsulphurmustard-induced
skin injury37 details considerable effort demonstrating the relationship between the amount
of nonextractable sulfur mustard in the skin and resultant injury. It documented that in
human skin, in contrast to pig and rabbit skin, sulfur mustard is almost maximally fixed
within 2 minutes of exposure. The ice-pack studies subsequently described were viewed as
confirmatory evidence that there was virtually no significant reservoir of unreacted sulfur
mustard in human skin very shortly after exposure. In this work, humans and pigs were
exposed to liquid mustard for 10 minutes, decontaminated with petroleum ether, and then
ice-packs were applied to the exposure sites. The results of these experiments were de-
scribed as “In man (Table 8), the ice-pack treatment did not significantly affect either the
amount of fixed H as determined 24 hours after exposure or the severity of the lesion that
developed. In the pig (Table 9), on the other hand, the ice-pack treatment resulted in the
fixation of considerably less H than would otherwise have been the case, and in the partial
or complete inhibition of visible injury development.”37 Thus, it was concluded that in the
pig, cooling exposed skin decreased the rate of sulfur mustard fixation, allowing it to be
slowly carried away by body fluids during the cooling treatment, whereas in man, cooling
was ineffective because virtually all sulfur mustard fixation occurred during exposure. In-
terestingly,althoughRenshawchosenottoincludecoolingasapossibletreatmentmodality
in his summary to this chapter, he referred to “Canadian experiments” as demonstrating
that if thorough decontamination of sulfur mustard–exposed skin is not carried out then
ice-pack treatment does reduce the severity of the skin injury. To this point, we have not
been able to locate the original documentation of these studies.
Effect of hypothermia on vesicant-induced toxicity
Our interest in the potential protective effects of cooling HD-exposed tissue did not arise
from historical considerations or from the hypothesis that hypothermia would prevent or
ameliorate the initial lesions that HD causes to eventually cause toxicity. Rather, our moti-
vation for examining temperature as a potential modulator of mustard toxicity was a result
of work carried out with a class of drugs that conferred significant protection against HD
toxicityinvitro.Thesecompoundswerenitricoxidesynthaseinhibitorswithstructuralsim-
ilaritiesto D/L-nitroargininemethylester(D/L-NAME).Althoughtheywereshowntoconfer
up to 300% protection against HD (in terms of median lethal concentration), this protection
was not mediated through nitric oxide synthase inhibition.41–43 While these findings were
in themselves interesting, what was also intriguing was that the efficacy of L-NAME in
cultures treated after HD exposure, remained maximal at 3 hours post–HD treatment, and
then only slowly declined over the next 5 hours. These findings were consistent with HD
rapidlyinitiatingitseffectsandsettingintomotionmetaboliceventsthatresultedinalesion
(inhibited by L-NAME) being first expressed by approximately 3 hours post–HD treatment
and fully expressed by about 8 hours post–HD treatment. This hypothesis could be easily
tested by altering the incubation temperatures of HD-treated cultures and examining the
effectoftemperatureontheefficacyof L-NAMEposttreatmentonHDtoxicity,asafunction
of time. These studies were subsequently carried out. Similar studies were also carried out
with L and the chelator dimercaptosuccinic acid (DMSA). Although both HD and L are
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Table 1. Comparative toxicity of vesicant agents in tissue culture∗
Median lethal concentration
Distilled sulfur mustard Lewisite
Human skin keratinocytes (proliferating) 4.16 ± 1.29 × 10−5 1.88 ± 0.24 × 10−7
Chick embryo neurons (differentiated) 5.25 ± 1.62 × 10−5 2.99 ± 1.78 × 10−7
CHO-K1 2.45 ± 0.37 × 10−4 1.83 ± 0.24 × 10−6
HeLa 1.93 ± 0.31 × 10−4 1.91 ± 0.19 × 10−6
J-774 4.53 ± 0.23 × 10−5 6.27 ± 0.19 × 10−7
∗Values represent mean ± SD of at least 3 separate experiments.
vesicant in nature, they are very different in how they exert their respective toxicities. A
comparison of their toxic effects was thus carried out both in vitro and in vivo.
The toxicity of the 2 agents was initially compared in cell cultures of widely varying
origins (Table 1). The toxicity of L was at least 2 orders of magnitude greater than that of
HD in differentiated chick embryo neurons, proliferating cultures of first passage human
skin keratinocytes, CHO-K1, and HeLa cells, and 70 times more toxic in J-774 cells. The
toxicities of HD and L were also assessed in studies using hairless guinea pigs (Fig 2), an
animalmodelthathasbeenshowntodevelopmicroblisteringoftheepidermiswhentheskin
is exposed to HD vapor for 2 to 8 minutes.44 In our laboratory, these 2 agents produced skin
injury in this animal model in different fashions.32,33 Four- and six-minute HD exposures
slowly produced visible lesions that were maximal by 72 hours. In contrast, 2- to 6-minute
Lv apor exposures produced lesions of much greater severity. Lewisite-induced skin injury
progressed very rapidly so that blood scabs were well formed at all exposure sites by 24
hours and of maximal severity by approximately 48 hours. Although the vapor pressure of
Li ss everal times higher than that of HD, it is significantly more cytotoxic and produces
much more severe skin injury than HD does under similar exposure conditions.
Effect of hypothermia on sulfur mustard–induced toxicity
The effect of temperature on the toxicity of HD has been well characterized in first passage
human skin keratinocyte cultures of varying differentiative states.35 The toxicity of HD
graduallydeclinedasthecellsweretestedinproliferating,just-confluent,orpost–confluent
stagesofculture.Nevertheless,inallcases,HDtoxicitywassignificantlyreducedbyholding
the cultures at 25◦C, as opposed to 37◦C. The effects of temperature were further examined
in proliferating cultures treated with HD32 and held at 25◦C, 31◦C, or 37◦C. At 37◦C, HD
toxicity was rapidly expressed and maximal by 48 hours postexposure. When the cells
were incubated at 31◦C, the 24-hour toxicity was significantly less than that exhibited at
37◦C, but the cells then progressively lost viability over the ensuing 4 days. At 25◦C, HD
toxicity on day 1 was similar to that at 31◦C, but increased only marginally with time so
that by day 4, toxicity was still significantly less than that exhibited in cultures incubated at
31◦Co r3 7 ◦C( Fig 3A). Extensive confirmatory evidence of the protective effect of lowered
temperature against HD toxicity was also obtained when apoptotic endpoints (morphology,
DNA fragmentation) were utilized.32 The protective effects of lowered temperature were
notpersistent.Whenculturesincubatedattheloweredtemperaturefor4dayswereswitched
back to 37◦C, the toxicity after 24 hours was similar to those of cultures incubated at 37◦C
for the entire 5-day time period (Fig 3A).
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Figure 2. Effect of vesicant vapor exposure on hairless guinea pig
skin.Vaporexposuresofeitherdistilledsulfurmustard(HD)ordistilled
lewisite (L) were carried out on hairless guinea pig skin for 2, 4, or 6
minutes. Results show the development of skin lesions at 7, 24, and 72
hours. Results depict the appearance of lesions on 3 animals and are
representative of several different experiments.
Although the transient protective effects of cooling HD-exposed cultures were not
promising with respect to obtaining positive outcomes in animal work, cooling of HD-
exposed hairless guinea pig skin at 10◦C for 6 hours (Fig 4) or at 5◦C for 4 hours was
protective in comparison with animals whose exposure sites were left at room temperature
whereassimilarcoolingregimensat15◦Cwerenot.Decreased,butstillsignificantprotection
was also obtained if cooling (5◦C) was delayed by 1 hour before 5 hours of cooling.32
Similar, but less extensive work examining the effect of cooling HD-exposed skin was
also carried out using 20-kg domestic swine.45 In these studies, longer HD vapor exposure
times (4–16 minutes) of the abdominal area were necessary to produce skin injury. The
4-hour ice-pack treatments used to obtain maximal protective effects in this animal model
only required the skin to be cooled to approximately 15◦Ct o2 0 ◦C. Cooling of HD-exposed
skin consistently resulted in less injury than exposure sites left at room temperature. How-
ever,theseverityofthelesionsproducedbyHDexposure,aswellastheprotectionafforded
by cooling,appearedtobesignificantlymorevariableinswinethanthatobservedinhairless
guinea pigs. As the structure of swine skin is significantly closer to that of human skin than
is guinea pig skin, this may suggest a similar variable response in humans.
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Figure 3. Effectofincubationtemperatureonthedevelopmentofdistilledsulfur
mustard (HD) and distilled lewisite (L) toxicity in human skin keratinocytes.
Proliferating cultures of first passage neonatal human skin keratinocytes were
treated with either HD (A) or L (B), and then incubated at 25◦C, 31◦C, or 37◦C.
At1,2,3,or4daysaftertreatment,uniquetestcultureswereassayedforviability
using alamarBlue. The HD-treated cultures assayed at 4 days, were refed, and
then incubated for an additional 24 hours at 37◦C before viability assessment.
Data represent the mean ± SEM of three different experiments using tissue from
three different donors, and was analyzed by analysis of variance and post hoc
Dunnett’s Method Comparison testing. ∗Significantly different from the median
lethal concentrationobtained at 24 hours at 37◦C, P <. 05.
As stated previously, our original goal in examining the effect of temperature on
vesicant-induced toxicity was to ascertain whether cooling HD-treated cell cultures would
result in an increase in the therapeutic window in which L-NAME was protective. This drug
iseffectiveagainstHDinjust-confluentculturesofhumanskinkeratinocytes.However,the
extremely rapid decline in HD toxicity with culture age, especially as the cultures became
confluent and differentiation was initiated, precluded reproducible protection studies in this
system. We, therefore, carried out this work in differentiated primary chick embryo neuron
cultures, a system that we have found to be very sensitive to the effects of HD, sensitive to
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the protective effects of L-NAME, and to be predictive of results obtained in human skin
keratinocytes.35 Lowering the incubation temperature of HD-exposed neurons significantly
lengthened the period of time in which L-NAME was still of therapeutic value (Fig 5A).
At 37◦C, 5.0 mM L-NAME was maximally effective when added 2 hours after the neurons
had been exposed to HD. This protection then gradually decreased until no significant
advantage was obtained 12 hours post–HD exposure. At 25◦C, maximal protection could
still be observed when adding the L-NAME up to 12 hours after HD exposure. No efforts
were made to duplicate these results in the hairless guinea pig model, since L-NAME was
not found to be protective in this model system, probably due to difficulties in obtaining
and maintaining sufficiently high concentrations at the HD target sites.35
Figure 4. Effect of cooling on skin lesions induced by sulfur mustard (HD) and
lewisite (L) vapor in hairless guinea pigs. Animals were exposed to HD or L
vapor for 2, 4, and 6 minutes. The exposure sites were then left at either room
temperature (top panels) or cooled (approximately 10◦C) for 4 hours (L) or 6
hours (HD, bottom panels). The figure depicts the appearance of skin lesions on
three animals at 72 hours posttreatment.
Effect of hypothermia on lewisite-induced toxicity
IncontrasttotheresultsobtainedwithHD,keratinocyteculturesexposedtoLandincubated
at25◦Crapidlylostviabilitywithtime(Fig3B).At37◦C,Ltoxicitywasalmostmaximalby
24hoursanddecreasedonlyslightlyduringthenext3days.At24hours,inculturesincubated
at 31◦C, the toxicity of L was reduced (but not statistically significant) in comparison with
that obtained at 37◦C. However, by 48 hours, this protective effect was lost and median
lethal concentration values were similar to those obtained at 37◦C. The protective effect of
lowered temperature was dramatic when the treated cultures were incubated at 25◦C. The
median lethal concentration values obtained at 24 hours were more than 12 times higher
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than those at 37◦C. However, these protective effects were rapidly lost over the following
days. Clearly, the development of HD toxicity in this culture system is more temperature
dependent than that of L.
Figure 5. Effect of incubation temperature on the efficacy of protective drug
treatments in cell cultures exposed to sulfur mustard (A) or lewisite (B). Mature
chick embryo neuron cultures were treated with 5.0 mM L-nitroarginine methyl
ester(L-NAME)atvaryingtimeintervalsafterHDexposureofculturesincubated
at 25◦Co r3 7 ◦C (A) and proliferating cultures of first passage cultures of human
skin keratinocytes were treated with 1.0 mM demercaptosuccinic acid (DMSA)
at varying time intervals after L exposure of cultures incubated at 25◦C, 31◦C, or
37◦C (B). Test cultures were assayed for viability using alamarBlueTM. Results
representthemean±SEMofthreeseparateexperimentsusingtissuefromdiffer-
ent donors, and were analyzed by analysis of variance and post hoc Tukey HSD
Multiple Comparison testing. * Significantly different from the median lethal
concentration of agent-only–treated cultures within the same test temperature,
P <. 05.
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Figure 6. Effect of incubation temperature on the efficacy of protective demer-
captosuccinic acid (DMSA) treatment after exposure of distilled lewisite (L) on
hairless guinea pig skin. Animals were exposed to L vapor for 2, 4, or 6 minutes.
At 2 minutes posttreatment, the exposure sites were treated topically with 50 µL
of vehicle (DMSO) only; (A) or DMSA (50 mg/mL, B) for 1 hour. In additional
treatment groups, the L exposure sites were left for 2 hours at room temperature
before being treated with DMSA (50 µLo f5 0mg/mL, C) for 1 hour, or the
exposure sites were cooled at approximately 10◦C for 2 hour before the 1-hour
treatment with DMSA (D). Three animals were used for each treatment and the
photographs depict the appearance of the lesions at 3 days posttreatment.
Lewisite produces much more toxicity in a shorter time frame, both in vitro and in
vivo than does HD. Thus, the results of the cooling experiments utilizing hairless guinea
pigs exposed to L were unexpected.33 Not only were the lesions caused by 2 to 6 minutes
Lv apor exposures very significantly reduced by cooling at 10◦C for as little as 30 min-
utes, but protection could still be obtained by cooling up to 1 hour post–L exposure. Per-
haps, most surprising was that the very serious skin injury produced by L vapor exposure
could almost be totally eliminated by cooling (Fig 4). Protection studies using DMSA and
Lw ere carried out in human skin keratinocytes. In contrast to the protective effects of
L-NAME against HD toxicity, which are only exhibited in differentiating cultures, DMSA
is also protective against L toxicity in proliferating cultures. Cultures were held at 25◦C,
31◦C, or 37◦Ce xposed to L, and then treated with 1.0 mM DMSA at 1, 3, 5, or 8 hours
postexposure.AfterDMSAtreatment,allcultureswerereturnedtoa37◦Cincubatorforthe
remainder of the 48 hour L exposure period. When the cultures were DMSA-treated at 1
hour post–L exposure, significant protection against L was obtained only at 25◦C, although
the viability at the other 2 temperatures was elevated. After this, the protective effects of
DMSA rapidly declined with time at all temperatures (Fig 5B). The relative success of
this in vitro work led us to examine the possibility that hypothermia may also result in an
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extendedDMSAtherapeuticwindowagainstLinhairlessguineapigs.33 Incomparisonwith
vehicle [dimethylsulphoxide (DMSO), Fig 6A] treatment only, a 1-hour DMSA treatment
immediately after L vapor exposure resulted in very significant protection, with only minor
skin injury evident at the 6-minute exposure sites (Fig 6B). Delaying the DMSA treatment
by2hours resulted in very good protection at the 2-minute and 4-minute L exposure sites,
but not at the 6-minute L exposure sites (Fig 6C). The severity of skin injury from this latter
treatment was similar to that obtained when the exposure sites were cooled for 2 hours.33
Combining these 2 treatments, so that DMSA was applied after 2 hours of cooling, totally
eliminated all signs of skin injury (Fig 6D). Even close examination of the exposure sites
failed to detect any difference from the surrounding tissue.
SUMMARY
There is a temptation to dismiss records of historical military research as primitive and/or
lacking in detail. Much of this work was driven by real-time military requirements, and re-
sults not relevant to the stated objectives of the project were often not recorded or pursued.
Thus, the scientific detail required to accurately assess some of the historical defense liter-
ature is often lacking. Nevertheless, the scientists involved in these endeavors, particularly
those working under the urgency of current or anticipated world conflict, were often the
finest that their countries had to offer. These studies also utilized human volunteers when
deemed necessary, an option that is not available to modern day CW researchers because
of current human ethical guidelines. It is thus important to objectively assess the poten-
tial practical importance of findings, using tissue culture and animals in light of historical
results, especially those that include human studies.
Tissueculturedatahavedefinitivelyshownthatcoolingslowsthedevelopmentofboth
HD- and L-induced cytotoxicity, and support the hypothesis that their toxicity is the result
of a metabolic cascade of events. This in vitro protection against HD is reversible in nature
and there is historical evidence supporting the notion that sulfur mustard is “fixed” (nonex-
tractable)veryquicklyinhumantissue,andthusnotamenabletocoolingtherapy.Fromthese
findings, one might conclude that cooling HD-exposed human skin would not result in any
significant permanent protective effects. However, recent work has demonstrated that there
isaverysignificantreservoirofunreactedHDinbothhumanandpigskinforupto24hours
after contamination of the skin surface in vitro, thus elevating the likelihood that cooling
HD-contaminated skin might indeed reduce resultant skin injury.46 Lewisite is less likely to
be fixed in the skin than would the alkylating agent HD, and it seems probable that cooling
L-exposed skin may also be effective in providing protection. As originally postulated by
Renshaw,37 with sulfur mustard, this would occur by lowering its (bio)chemical reactivity,
while allowing the systemic circulation to slowly transport the unreacted agent away from
the site of exposure. It is also likely that an important aspect of cooling vesicant-exposed
skin would be by increasing the therapeutic window in which medical countermeasures
against these CW agents may be applied. Tissue culture studies show that cooling does in-
crease this window of opportunity for protective drug treatments, most probably by slowing
metabolism. Therapeutic medical intervention of HD- or L-induced injury may be possible
by blocking events downstream from the initial lesion, whether the agent is “fixed” or not.
This approach may presently be successful with chelation therapy against L, and in the
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future with HD when effective medical countermeasures against this agent are developed.
The noninvasive and simple act of cooling vesicant-exposed skin, while not practical for
large body surfaces, may provide a facile means of reducing vesicant-induced cutaneous
injury.
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